From May 2021 to May 2022, more than 103,000 Americans died from a drug overdose, making it a leading cause of death in the US. Despite this, insurance still dictates what you get in addiction treatment.
Payers minimize costs by shortening treatment timelines even if decades of research point to more success with longer engagements. But it doesn’t have to be this way; data access and collaboration can unlock better outcomes for all. This kind of “radical collaboration” is only possible if all stakeholders—payers and providers—commit to a data-informed and enriched understanding of the patient’s journey to recovery.
Want the full story? Get the scoop from Nicholas Hayes, Chief Science Officer at Cumberland Heights, a Sunwave Health partner, here. (6 minute read)
